Cases 31 - 40 of 71
Otsuka Pharmaceutical Co., Ltd. et al v. Alkem Laboratories Ltd.
as 1:2020cv01286
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
as 1:2020cv01094
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Azurity Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH HEALTH US, LLC et al v. ALKEM LABORATORIES LTD.
as 3:2020cv02737
Plaintiff:
BAUSCH HEALTH US, LLC, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH AMERICAS, INC. and others
Defendant:
ALKEM LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
Relypsa, Inc. et al v. Alkem Laboratories Ltd. et al
as 1:2020cv00106
Plaintiff:
Vifor (International) Ltd. and Relypsa, Inc.
Defendant:
Alkem Laboratories Ltd. and Ascent Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Silvergate Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
as 1:2019cv02100
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Silvergate Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Alkem Laboratories Ltd.
as 1:2019cv01964
Defendant:
Alkem Laboratories Ltd.
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v Alkem Laboratories Ltd.
as 1:2019cv01493
Defendant:
Ascend Laboratories, LLC and Alkem Laboratories Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
